MedPath

Fecal Transplant for MDRO Decolonization

Not Applicable
Conditions
Multi-antibiotic Resistance
Interventions
Biological: Fecal Microbiota Transplantation (FMT)
Registration Number
NCT04181112
Lead Sponsor
University of British Columbia
Brief Summary

This is a trial designed to determine whether fecal microbiota transplantation (FMT) can eliminate highly drug-resistant bacteria from the intestinal tract of renal transplant patients. The primary goal of this study is to test whether oral gut decontamination followed by FMT using enema delivery will result in decolonization of the intestinal tract of renal transplant patients shortly after solid organ transplantation, thereby preventing difficult to treat post-transplant infections.

Detailed Description

Contact the study principal investigator for the study protocol.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fecal microbiota transplantationFecal Microbiota Transplantation (FMT)-
Fecal microbiota transplantation with antibiotic pre-treatmentFecal Microbiota Transplantation (FMT)-
Primary Outcome Measures
NameTimeMethod
The elimination of the target multi-drug resistant organism (MDRO), using culture and molecular test-based screening of recipient stool, at both the 14 and 30 days post-FMT.3 years
Secondary Outcome Measures
NameTimeMethod
Compare proportions, type and timing of adverse events post-FMT3 years
Proportions of recolonization over 180 days3 years
Timing of recolonization over 180 days3 years

Trial Locations

Locations (2)

Vancouver Coastal Health - Vancouver General Hospital

🇨🇦

Vancouver, British Columbia, Canada

Providence Health Care - St. Paul's Hospital

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath